2011
DOI: 10.1111/j.1365-2036.2010.04565.x
|View full text |Cite
|
Sign up to set email alerts
|

Review article: the clinical relevance of transient lower oesophageal sphincter relaxations in gastro-oesophageal reflux disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
42
0
4

Year Published

2012
2012
2019
2019

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 53 publications
(47 citation statements)
references
References 125 publications
(170 reference statements)
1
42
0
4
Order By: Relevance
“…Thus the objective criteria used to identify TLESR during our experiments were based on the manometric profile of the LES (8) . This technique enables continuous measurement of LES pressure and leading to a better comprehension of GERD, by identifying TLESR as the main permissive mechanism for GERD (18) .…”
Section: Discussionmentioning
confidence: 99%
“…Thus the objective criteria used to identify TLESR during our experiments were based on the manometric profile of the LES (8) . This technique enables continuous measurement of LES pressure and leading to a better comprehension of GERD, by identifying TLESR as the main permissive mechanism for GERD (18) .…”
Section: Discussionmentioning
confidence: 99%
“…The most important mechanism is the failure of the anti-reflux barrier, known as lower esophageal sphincter (LES), which is composed by the own esophageal muscle and the diaphragmatic crus. The transient LES relaxation (TLESRs) triggered during post-prandial gastric distension is the main event during which the gastric content is propelled into the esophagus [8,9]. Furthermore, several risk factors have been associated with GERD, in particular obesity, dietary habits and emotional disturbances [10].…”
Section: Pathophysiologymentioning
confidence: 99%
“…Many receptors in central nervous system is involved in TLESR, hence several approaches for TLESR inhibitors mediated through GABAB, metabolic glutamine (mGlu) and cannabinoid (CB) receptors have been developed to enhance the lower esophageal sphincter constriction for blocking the gastric acid and non-acid reflux. Although GABAB receptor agonist (baclofen, R-baclofen, AZD9343, lesogaberan: AZD3355), mGlu receptor 5 antagonist (ADX10059, AZD2066, AZD2516) and CB1 agonist (D9-THC) reduced the TLESR, central nerve side effects such as headache and drowsiness, and low compliance (need to be taken twice or three times a day) were observed in clinical studies [Blondeau, 2010;Kessing et al, 2011]. Lesogaberan which was administered twice daily as add-on treatment to PPI ameliorated heartburn and regurgitation symptoms in persistent GERD symptoms even daily PPI therapy [Boeckxstaens et al, 2011]; however these effects were not adequate.…”
Section: Tlesr Inhibitormentioning
confidence: 99%
“…TLESR is an episode of lower esophageal relaxation that occurs unrelated to swallowing [Kessing et al, 2011], and it is considered to be the underlying refractory factors for GERD treatment with PPIs. Many receptors in central nervous system is involved in TLESR, hence several approaches for TLESR inhibitors mediated through GABAB, metabolic glutamine (mGlu) and cannabinoid (CB) receptors have been developed to enhance the lower esophageal sphincter constriction for blocking the gastric acid and non-acid reflux.…”
Section: Tlesr Inhibitormentioning
confidence: 99%